Literature DB >> 29331211

Emerging Mechanisms in Alzheimer's Disease and Their Therapeutic Implications.

Stephen M Strittmatter1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29331211      PMCID： PMC5840867          DOI： 10.1016/j.biopsych.2017.12.002

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  21 in total

Review 1.  Untangling Genetic Risk for Alzheimer's Disease.

Authors:  Anna A Pimenova; Towfique Raj; Alison M Goate
Journal:  Biol Psychiatry       Date:  2017-05-22       Impact factor: 13.382

2.  Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy.

Authors:  Kiran Yanamandra; Tirth K Patel; Hong Jiang; Suzanne Schindler; Jason D Ulrich; Adam L Boxer; Bruce L Miller; Diana R Kerwin; Gilbert Gallardo; Floy Stewart; Mary Beth Finn; Nigel J Cairns; Philip B Verghese; Ilana Fogelman; Tim West; Joel Braunstein; Grace Robinson; Jennifer Keyser; Joseph Roh; Stephanie S Knapik; Yan Hu; David M Holtzman
Journal:  Sci Transl Med       Date:  2017-04-19       Impact factor: 17.956

Review 3.  Prion-like Spreading in Tauopathies.

Authors:  Jacob I Ayers; Benoit I Giasson; David R Borchelt
Journal:  Biol Psychiatry       Date:  2017-04-13       Impact factor: 13.382

Review 4.  Modulation of γ- and β-Secretases as Early Prevention Against Alzheimer's Disease.

Authors:  Iryna Voytyuk; Bart De Strooper; Lucía Chávez-Gutiérrez
Journal:  Biol Psychiatry       Date:  2017-08-10       Impact factor: 13.382

5.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

Authors:  S T DeKosky; S W Scheff
Journal:  Ann Neurol       Date:  1990-05       Impact factor: 10.422

6.  Variant of TREM2 associated with the risk of Alzheimer's disease.

Authors:  Thorlakur Jonsson; Hreinn Stefansson; Stacy Steinberg; Ingileif Jonsdottir; Palmi V Jonsson; Jon Snaedal; Sigurbjorn Bjornsson; Johanna Huttenlocher; Allan I Levey; James J Lah; Dan Rujescu; Harald Hampel; Ina Giegling; Ole A Andreassen; Knut Engedal; Ingun Ulstein; Srdjan Djurovic; Carla Ibrahim-Verbaas; Albert Hofman; M Arfan Ikram; Cornelia M van Duijn; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

7.  Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.

Authors:  Juha Laurén; David A Gimbel; Haakon B Nygaard; John W Gilbert; Stephen M Strittmatter
Journal:  Nature       Date:  2009-02-26       Impact factor: 49.962

8.  TREM2 variants in Alzheimer's disease.

Authors:  Rita Guerreiro; Aleksandra Wojtas; Jose Bras; Minerva Carrasquillo; Ekaterina Rogaeva; Elisa Majounie; Carlos Cruchaga; Celeste Sassi; John S K Kauwe; Steven Younkin; Lilinaz Hazrati; John Collinge; Jennifer Pocock; Tammaryn Lashley; Julie Williams; Jean-Charles Lambert; Philippe Amouyel; Alison Goate; Rosa Rademakers; Kevin Morgan; John Powell; Peter St George-Hyslop; Andrew Singleton; John Hardy
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

Review 9.  Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.

Authors:  Na Zhao; Chia-Chen Liu; Wenhui Qiao; Guojun Bu
Journal:  Biol Psychiatry       Date:  2017-03-14       Impact factor: 12.810

Review 10.  The amyloid hypothesis of Alzheimer's disease at 25 years.

Authors:  Dennis J Selkoe; John Hardy
Journal:  EMBO Mol Med       Date:  2016-06-01       Impact factor: 12.137
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.